Skip to main content
OpenTrials
Completed

NCT Number: NCT02307331

RSA Study of Sirius Stem and Exceed Cup

The purpose of this study is to evaluate the efficacy and safety of the Sirius Cemented Stem used in conjunction with the Exceed ABT Cemented Acetabular Cup, either with E1 or Arcom polyethylene, and OptiPac/OptiVac bone cement mixing systems.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Deot of Orthopedics, Skane University Hospital, Lund University

Lund, 221 85, Sweden

About this study

This is a comparative, prospective randomized Radiostereometry (RSA) study, lead on 48 patients in a single site.

All 48 patients will be pooled in a single group for the evaluation of the primary criterion for evaluation, but randomized into four groups for the evaluation of the secondary criteria for evaluation

The objectives of the study are to:

  • Demonstrate a comparable migration pattern as is described in published literature on other double tapered polished cemented stems
  • Measure wear pattern in the cup made of vitamin-E doped polyethylene or conventional Arcom polyethylene

2)Demonstrate non-inferiority of Optipac vs. Optivac cement mixing systems on the stem side 3)Evaluate the clinical outcome and survivorship of the implant

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who are eligible for cemented total hip arthroplasty
  • Patients diagnosed with primary Osteoarthritis
  • Patients who are fit for elective surgery (ASA I - III)
  • Patients with a BMI between 16 and 40
  • Patients who are skeletally mature
  • Patients aged over 18 at the time of surgery
  • Patients willing to return for follow-up evaluations
  • Patients who have the ability to follow instructions
  • Patients with sufficient bone stock and quality

Exclusion criteria

  • Female patients who are pregnant or planning pregnancy during the course of the study (no use of adequate birth control)
  • Patients with diagnosed active infection
  • Patients with marked bone loss which could preclude or compromise adequate fixation of the device
  • Patients with Parkinson disease
  • Patients using immunosuppressive drugs
  • Patients with an immunosuppressive disease
  • Patients with BMI <16
  • Patient with BMI >40
  • Patients who are unfit for surgery (ASA IV - V)
  • Patients with acetabular or femoral osteotomy
  • Patients who had a THA on the contralateral side within last 6 months
  • Patients belonging to the vulnerable population: children, patients with mental

Treatment and study plan

Optivac

Device

A vacuum mixing system for cement with mixing and collection under vacuum but open initial mixture of powder and monomer. Has been used since 1993 with excellent results

Optipac

Device

A vacuum mixing system for cement with mixing and collection under vacuum but with a pre-packed mixing system allowing for an all closed system minimizing exposure for monomer fumes. This is a relatively new mixing system

Arcom (Exceed cup)

Device

The Exceed cup is available in two type of advanced bearing polyethylene material: The first is the 'classic', long term proven ArCom, a conventional polyethylene

E1 (Exceed cup)

Device

The Exceed cup is available in two type of advanced bearing polyethylene material: The new is a highly cross linked polyethylene with infusion of vitamin E1 to remove free radicals in order to reduce wear.

Sirius stem

Device

A polished tapered stem

Primary outcomes

  1. Radiostereometry (RSA) - change in migration and wear over time

    Time frame: First postoperative day, 3 months, 1 year, 2 years and 5 years

    Prosthesis migration and cup wear are measured over time, from baseline directly postop up to 5years. Measures are given in change in mm (translation) and degrees (rotation) around x, y and z-axis.

Secondary outcomes

  1. Conventional Radiography (Signs of radiolucent lines or obvious change of position will be measured in mm)

    Time frame: First postoperative day, 2 years and 5 years

    Signs of radiolucent lines or obvious change of position will be measured in mm

  2. HOOS (Hip specific health questionnaire)

    Time frame: Preoperatively, 1 year, 2 years and 5 years

    Hip specific health questionnaire - HOOS

  3. EQ5D

    Time frame: Preoperatively, 1 year, 2 years and 5 years

    General health questionnaire - EQ-5D

Sponsors and collaborators

Lead sponsor

Region Skane

Other

Collaborators

  • Zimmer Biomet

Registry information

Official study title

RCT of the Sirius Stem Used in Conjunction With the Exceed ABT Cemented Cup and OptiPac/OptiVac Cement - Model Based RSA, Clinical and Radiographic Outcomes

Important dates

Study start
2014
Primary completion
2020
Study completion
2023
First posted
Dec 4, 2014
Registry last updated
Sep 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.